Hanyujie Kang

1.5k total citations
23 papers, 660 citations indexed

About

Hanyujie Kang is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Hanyujie Kang has authored 23 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Infectious Diseases and 5 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Hanyujie Kang's work include COVID-19 Clinical Research Studies (8 papers), Respiratory Support and Mechanisms (8 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Hanyujie Kang is often cited by papers focused on COVID-19 Clinical Research Studies (8 papers), Respiratory Support and Mechanisms (8 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Hanyujie Kang collaborates with scholars based in China, United States and Taiwan. Hanyujie Kang's co-authors include Zhaohui Tong, Yishan Wang, Xuefeng Liu, Zhaohui Tong, Xuyan Li, Haibo Qiu, Yishan Wang, Bin Du, Ruiqiang Zheng and Bing Sun and has published in prestigious journals such as Frontiers in Immunology, Ecotoxicology and Environmental Safety and BMJ Open.

In The Last Decade

Hanyujie Kang

22 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanyujie Kang China 10 426 143 114 111 94 23 660
Cheng Feng China 11 390 0.9× 141 1.0× 94 0.8× 226 2.0× 78 0.8× 30 767
Changfeng Dong China 10 382 0.9× 103 0.7× 61 0.5× 221 2.0× 80 0.9× 24 687
Paula Zambrano-Achig Ecuador 5 460 1.1× 168 1.2× 45 0.4× 55 0.5× 120 1.3× 12 670
Jinxin Liu China 4 399 0.9× 216 1.5× 65 0.6× 202 1.8× 30 0.3× 11 586
Inès Saab France 6 395 0.9× 248 1.7× 80 0.7× 146 1.3× 37 0.4× 6 621
Stefano Pelenghi Italy 9 561 1.3× 50 0.3× 77 0.7× 311 2.8× 68 0.7× 33 841
Tanveer Mir United States 14 208 0.5× 68 0.5× 101 0.9× 78 0.7× 39 0.4× 107 656
Neeraj G. Patel United States 4 363 0.9× 112 0.8× 51 0.4× 46 0.4× 85 0.9× 7 535
Deyang Huang China 4 396 0.9× 213 1.5× 64 0.6× 195 1.8× 29 0.3× 6 571
Wouter M. van Everdingen Netherlands 13 318 0.7× 349 2.4× 106 0.9× 147 1.3× 57 0.6× 28 855

Countries citing papers authored by Hanyujie Kang

Since Specialization
Citations

This map shows the geographic impact of Hanyujie Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanyujie Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanyujie Kang more than expected).

Fields of papers citing papers by Hanyujie Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanyujie Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanyujie Kang. The network helps show where Hanyujie Kang may publish in the future.

Co-authorship network of co-authors of Hanyujie Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Hanyujie Kang. A scholar is included among the top collaborators of Hanyujie Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanyujie Kang. Hanyujie Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Hanyujie, et al.. (2024). Integrated multi-omics analyses reveal the pro-inflammatory and pro-fibrotic pulmonary macrophage subcluster in silicosis. Ecotoxicology and Environmental Safety. 284. 116899–116899. 3 indexed citations
2.
Kang, Hanyujie, et al.. (2024). The systemic immune-inflammation index is significantly associated with the severity of silicosis: a 9-year retrospective study in Beijing. Frontiers in Medicine. 11. 1351589–1351589. 2 indexed citations
3.
Kang, Hanyujie, et al.. (2024). Effect of Extended Prone Positioning in Intubated COVID-19 Patients with Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis. Journal of Intensive Care Medicine. 39(11). 1164–1172. 2 indexed citations
4.
Kang, Hanyujie, et al.. (2024). Blockade of TREM2 ameliorates pulmonary inflammation and fibrosis by modulating sphingolipid metabolism. Translational research. 275. 1–17. 4 indexed citations
5.
Kang, Hanyujie, et al.. (2023). Metabolomic Profiling of Lungs from Mice Reveals the Variability of Metabolites in Pneumocystis Infection and the Metabolic Abnormalities in BAFF-R-Deficient Mice. Journal of Inflammation Research. Volume 16. 1357–1373. 1 indexed citations
6.
Zhang, Zhijin, et al.. (2022). The efficiency of convalescent plasma in COVID-19 patients: A systematic review and meta-analysis of randomized controlled clinical trials. Frontiers in Immunology. 13. 964398–964398. 6 indexed citations
7.
Yang, Yuan, Juan Du, Yishan Wang, et al.. (2022). Prognostic impact of pleural effusion in patients with malignancy: A systematic review and meta‐analysis. Clinical and Translational Science. 15(6). 1340–1354. 12 indexed citations
8.
Li, Xuyan, Ming Hu, Ruiqiang Zheng, et al.. (2021). Delayed Initiation of ECMO Is Associated With Poor Outcomes in Patients With Severe COVID-19: A Multicenter Retrospective Cohort Study. Frontiers in Medicine. 8. 716086–716086. 19 indexed citations
11.
Qiu, Haibo, Xuyan Li, Bin Du, et al.. (2020). [The keypoints in treatment of the critical coronavirus disease 2019 patient(1)].. PubMed. 43(4). 273–277. 21 indexed citations
13.
Kang, Hanyujie, et al.. (2020). Personal knowledge on novel coronavirus pneumonia. Chinese Medical Journal. 133(9). 1121–1122. 3 indexed citations
14.
Wang, Yishan, et al.. (2020). Effect of convalescent blood products for patients with severe acute respiratory infections of viral etiology: A systematic review and meta-analysis. International Journal of Infectious Diseases. 102. 397–411. 7 indexed citations
15.
Wang, Yishan, Hanyujie Kang, Xuefeng Liu, & Zhaohui Tong. (2020). Asymptomatic cases with SARS‐CoV‐2 infection. Journal of Medical Virology. 92(9). 1401–1403. 34 indexed citations
16.
Kang, Hanyujie, Yishan Wang, Zhaohui Tong, & Xuefeng Liu. (2020). Retest positive for SARS‐CoV‐2 RNA of “recovered” patients with COVID‐19: Persistence, sampling issues, or re‐infection?. Journal of Medical Virology. 92(11). 2263–2265. 78 indexed citations
17.
Xie, Jianfeng, Daniel Hungerford, Hui Chen, et al.. (2020). Development and External Validation of a Prognostic Multivariable Model on Admission for Hospitalized Patients with COVID-19. SSRN Electronic Journal. 63 indexed citations
18.
Wang, Yishan, Hanyujie Kang, Xuefeng Liu, & Zhaohui Tong. (2020). Combination of RT‐qPCR testing and clinical features for diagnosis of COVID‐19 facilitates management of SARS‐CoV‐2 outbreak. Journal of Medical Virology. 92(6). 538–539. 283 indexed citations
19.
Kang, Hanyujie, Zhiling Zhao, & Zhaohui Tong. (2019). Effect of High-Flow Nasal Cannula Oxygen Therapy in Immunocompromised Subjects With Acute Respiratory Failure. Respiratory Care. 65(3). 369–376. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026